Race-Dependent Association of High-Density Lipoprotein Cholesterol Levels With Incident Coronary Artery Disease.

[1]  N. Roetker,et al.  A Brief Introduction to Competing Risks in the Context of Kidney Disease Epidemiology. , 2022, Kidney360.

[2]  V. Howard,et al.  High triglyceride to HDL cholesterol ratio is associated with increased coronary heart disease among White but not Black adults , 2021, American journal of preventive cardiology.

[3]  S. Bakker,et al.  High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events , 2021, Circulation.

[4]  P. Joshi,et al.  Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity , 2020, Circulation.

[5]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association , 2020, Circulation.

[6]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[7]  A. Tall,et al.  Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[8]  D. Rader,et al.  Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study , 2018, Cardiovascular research.

[9]  G. Davey Smith,et al.  Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians , 2018, British Medical Journal.

[10]  C. Yancy,et al.  Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association , 2017, Circulation.

[11]  B. Nordestgaard,et al.  Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies , 2017, European heart journal.

[12]  J. Richman,et al.  Black-White Differences in Incident Fatal, Nonfatal, and Total Coronary Heart Disease , 2017, Circulation.

[13]  Daniel R. Lavage,et al.  Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease , 2017, Circulation research.

[14]  V. Howard,et al.  Stroke symptoms and risk for incident coronary heart disease in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. , 2016, International journal of cardiology.

[15]  F. Rosendaal,et al.  No P Please , 2016, Journal of Thrombosis and Haemostasis.

[16]  Hui Zhou,et al.  Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies , 2016, Circulation.

[17]  R. Kronmal,et al.  10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). , 2015, Journal of the American College of Cardiology.

[18]  J. Shikany,et al.  Race-sex differences in the management of hyperlipidemia: the REasons for Geographic and Racial Differences in Stroke study. , 2015, American journal of preventive medicine.

[19]  A. Khera,et al.  Relation of Black Race between High Density Lipoprotein Cholesterol Content, High Density Lipoprotein Particles and Coronary Events (From the Dallas Heart Study) , 2015, The American journal of cardiology.

[20]  A. Khera,et al.  HDL cholesterol efflux capacity and incident cardiovascular events. , 2014, The New England journal of medicine.

[21]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[22]  Lihui Zhao,et al.  Coronary Heart Disease Risks Associated with High Levels of HDL Cholesterol , 2014, Journal of the American Heart Association.

[23]  P. Jose,et al.  Racial/Ethnic Differences in Dyslipidemia Patterns , 2014, Circulation.

[24]  M. Carroll,et al.  Total and high-density lipoprotein cholesterol in adults: National Health and Nutrition Examination Survey, 2011-2012. , 2013, NCHS data brief.

[25]  C. Moy,et al.  Racial differences in the impact of elevated systolic blood pressure on stroke risk. , 2013, JAMA internal medicine.

[26]  C. Lewis,et al.  Association of race and sex with risk of incident acute coronary heart disease events. , 2012, JAMA.

[27]  T. Ogihara,et al.  Association of Genetic Variants Influencing Lipid Levels with Coronary Artery Disease in Japanese Individuals , 2012, PLoS ONE.

[28]  John Spertus,et al.  Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study , 2012, The Lancet.

[29]  Samia Mora,et al.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). , 2012, Journal of the American College of Cardiology.

[30]  E. Boerwinkle,et al.  Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. , 2011, Atherosclerosis.

[31]  Robert L Wilensky,et al.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.

[32]  J. Danesh,et al.  Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.

[33]  A. Zwinderman,et al.  High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants. , 2008, Atherosclerosis.

[34]  J. Menzin,et al.  Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey , 2008 .

[35]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.

[36]  Christina Lindahl,et al.  High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. , 2008, Journal of the American College of Cardiology.

[37]  J. Alpert,et al.  Universal definition of myocardial infarction. , 2007, European heart journal.

[38]  C. Moy,et al.  The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and Design , 2005, Neuroepidemiology.

[39]  Ali H. Mokdad,et al.  State of Disparities in Cardiovascular Health in the United States , 2005, Circulation.

[40]  G. Mensah.  Eliminating Disparities in Cardiovascular Health: Six Strategic Imperatives and a Framework for Action , 2005, Circulation.

[41]  Shankuan Zhu,et al.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of internal medicine.

[42]  Daniel W. Jones,et al.  Risk factors for coronary heart disease in African Americans: the atherosclerosis risk in communities study, 1987-1997. , 2002, Archives of internal medicine.

[43]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[44]  P. Metcalf,et al.  African American-white differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. , 1998, American journal of epidemiology.

[45]  A. von Eckardstein,et al.  High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. , 1996, Atherosclerosis.

[46]  G. Assmann,et al.  Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study. , 1992, The American journal of cardiology.

[47]  B. Jacobsen,et al.  The Tromsø Heart Study: food habits, serum total cholesterol, HDL cholesterol, and triglycerides. , 1987, American journal of epidemiology.

[48]  P. Wilson,et al.  HDL-cholesterol in a sample of black adults: the Framingham Minority Study. , 1983, Metabolism: clinical and experimental.

[49]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[50]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[51]  V. Howard,et al.  Prevalence of hypertension by duration and age at exposure to the stroke belt. , 2010, Journal of the American Society of Hypertension : JASH.

[52]  H. Tunstall-Pedoe,et al.  Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies , 2003 .

[53]  Eliminating Racial,et al.  COMMITTEE ON UNDERSTANDING AND ELIMINATING RACIAL AND ETHNIC DISPARITIES IN HEALTH CARE , 2003 .

[54]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[55]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[56]  J. Medalie,et al.  Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.